(Q44628163)

4 December 2017

Evolving immunosuppressive microenvironment during human cervical carcinogenesis (English)

1 reference

4 December 2017

1 reference

A Kobayashi

1

1 reference

4 December 2017

V Weinberg

series ordinal

2

1 reference

4 December 2017

T Darragh

series ordinal

3

1 reference

4 December 2017

K Smith-McCune

series ordinal

4

1 reference

4 December 2017

2 July 2008

1 reference

4 December 2017

1 reference

4 December 2017

1

1 reference

4 December 2017

412-420

1 reference

4 December 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1038/mi.2008.33

4 December 2017

0 references

cites work

Immunological events in regressing genital warts

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

Regression of low-grade squamous intra-epithelial lesions in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Epidemiologic classification of human papillomavirus types associated with cervical cancer

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

https://api.crossref.org/works/10.1038%2FMI.2008.33

1 reference

7 January 2021

Distinct role of macrophages in different tumor microenvironments

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Tumour-educated macrophages promote tumour progression and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Macrophage polarization comes of age.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Role of tumor-associated macrophages in tumor progression and invasion

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Cancer and the chemokine network

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Dendritic cell dysfunction in cancer: a mechanism for immunosuppression

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Immunosuppressive networks in the tumour environment and their therapeutic relevance

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Characterization of Dendritic Cells that Induce Tolerance and T Regulatory 1 Cell Differentiation In Vivo

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Regulation of immune responses by L-arginine metabolism

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Regulation of T cell activation and tolerance by PDL2

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: Analysis by in situ hybridization

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Human papillomavirus type 16 and 18 gene expression in cervical neoplasias

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Indoleamine 2,3-dioxygenase is necessary for cytolytic activity of natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Tumor-driven evolution of immunosuppressive networks during malignant progression

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Dendritic cells in peripheral tolerance and immunity.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression--clinicopathological correlation

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Inverse modulation of intraepithelial Langerhans' cells and stromal macrophage/dendrocyte populations in human papillomavirus-associated squamous intraepithelial lesions of the cervix

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Immunohistochemical demonstration of histiocytes in normal ectocervical epithelium and epithelial lesions of the uterine cervix

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Quantitative analysis of IL-10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

The immunobiology of cancer immunosurveillance and immunoediting

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Cancer immunoediting from immune surveillance to immune escape

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Interferon-gamma (IFN-gamma): a possible prognostic marker for clearance of high-risk human papillomavirus (HPV)

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2008.33

7 January 2021

Identifiers

DOI

10.1038/MI.2008.33

1 reference

4 December 2017

1 reference